Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP337771.RAcblT05B1oVJosWRbpqFYhVLSrD5fz6v4EULRyiab1ag130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337771.RAcblT05B1oVJosWRbpqFYhVLSrD5fz6v4EULRyiab1ag130_provenance.
• assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP442136.RAPcDe6SNjo41pWpRZj4oWHjb-CbvCTiXhNlwMKJCu41M130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442136.RAPcDe6SNjo41pWpRZj4oWHjb-CbvCTiXhNlwMKJCu41M130_provenance.
• assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP229345.RAf75Bw9_HG1LKqDG0oMJFiycknHkmzTT73DSL-3rFKvk130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229345.RAf75Bw9_HG1LKqDG0oMJFiycknHkmzTT73DSL-3rFKvk130_provenance.
• assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP684348.RAF2ySc7aPgcqMWXmp9vz2J6lCJGvFAMKrZOye4Qy7Fyw130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684348.RAF2ySc7aPgcqMWXmp9vz2J6lCJGvFAMKrZOye4Qy7Fyw130_provenance.
• NP966905.RAb0u25vN6qzYj3dcTLvDO__WTu0fy4ObwB9ouEJ1A-7k130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966905.RAb0u25vN6qzYj3dcTLvDO__WTu0fy4ObwB9ouEJ1A-7k130_provenance.
• NP966906.RABDt4-jXX3Av5y9eDS23GlEhRaLempMjIw-9T9Di0uDs130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966906.RABDt4-jXX3Av5y9eDS23GlEhRaLempMjIw-9T9Di0uDs130_provenance.
• NP966902.RAvV5FqcEinB9kln0ULJ1IiojpXSnaLmJlwhaIpPKq1hk130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966902.RAvV5FqcEinB9kln0ULJ1IiojpXSnaLmJlwhaIpPKq1hk130_provenance.
• NP966903.RAk7W0o6c0O7KW_XGXGernpuEXDw0IqP3tZVojF35IdXs130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966903.RAk7W0o6c0O7KW_XGXGernpuEXDw0IqP3tZVojF35IdXs130_provenance.
• NP255401.RA5CHrGx7ztSt7o3mKH8FbscmD8pUVJJDj9_KGVioE4RA130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255401.RA5CHrGx7ztSt7o3mKH8FbscmD8pUVJJDj9_KGVioE4RA130_provenance.
• NP432970.RA1S_4aP-1fpeGstchPmR-S8NX0M-nmG2-szqxOLDxcmc130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432970.RA1S_4aP-1fpeGstchPmR-S8NX0M-nmG2-szqxOLDxcmc130_provenance.
• NP230189.RALxHh5MHA4Jh_CRd3tlPsGM2sg3geh_95xq87oiDFi8Y130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230189.RALxHh5MHA4Jh_CRd3tlPsGM2sg3geh_95xq87oiDFi8Y130_provenance.
• NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_provenance.
• NP966900.RAynytJ136VEdU3bKg7SbtizqMoQJ_py_PoJLvfB2vVHY130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966900.RAynytJ136VEdU3bKg7SbtizqMoQJ_py_PoJLvfB2vVHY130_provenance.